These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25454461)

  • 41. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells.
    Brünner-Kubath C; Shabbir W; Saferding V; Wagner R; Singer CF; Valent P; Berger W; Marian B; Zielinski CC; Grusch M; Grunt TW
    Breast Cancer Res Treat; 2011 Sep; 129(2):387-400. PubMed ID: 21046231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulphur doped carbon dots enhance photodynamic therapy via PI3K/Akt signalling pathway.
    Li Y; Wu S; Zhang J; Zhou R; Cai X
    Cell Prolif; 2020 May; 53(5):e12821. PubMed ID: 32364266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
    Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
    Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy.
    Kocanova S; Buytaert E; Matroule JY; Piette J; Golab J; de Witte P; Agostinis P
    Apoptosis; 2007 Apr; 12(4):731-41. PubMed ID: 17219054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
    Lai Y; Yu X; Lin X; He S
    Int J Mol Med; 2016 Feb; 37(2):369-77. PubMed ID: 26707081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest.
    Li S; Lin J; Wei J; Zhou L; Wang P
    J Environ Pathol Toxicol Oncol; 2022; 41(3):33-43. PubMed ID: 35993954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypericin-photodynamic therapy induces human umbilical vein endothelial cell apoptosis.
    Zhang Q; Li ZH; Li YY; Shi SJ; Zhou SW; Fu YY; Zhang Q; Yang X; Fu RQ; Lu LC
    Sci Rep; 2015 Dec; 5():18398. PubMed ID: 26673286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins.
    Helander L; Sharma A; Krokan HE; Plaetzer K; Krammer B; Tortik N; Gederaas OA; Slupphaug G; Hagen L
    Mol Biosyst; 2016 Mar; 12(3):796-805. PubMed ID: 26742548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K/AKT/mTOR and DNA damage response pathways.
    Zhang Y; Cong L; He J; Wang Y; Zou Y; Yang Z; Hu Y; Zhang S; He X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):567-578. PubMed ID: 29718150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triclosan induces PC12 cells injury is accompanied by inhibition of AKT/mTOR and activation of p38 pathway.
    Li SJ; Chen P; Peres TV; Villahoz BF; Zhang Z; Miah MR; Aschner M
    Neurotoxicology; 2019 Sep; 74():221-229. PubMed ID: 31381933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein kinases as targets for developing anticancer agents from marine organisms.
    Qiao G; Bi K; Liu J; Cao S; Liu M; Pešić M; Lin X
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129759. PubMed ID: 33038451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor.
    Hayashida Y; Ikeda Y; Sawada K; Kawai K; Kato T; Kakehi Y; Araki N
    Int J Cancer; 2016 Aug; 139(3):700-11. PubMed ID: 26989815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner.
    Heberle AM; Razquin Navas P; Langelaar-Makkinje M; Kasack K; Sadik A; Faessler E; Hahn U; Marx-Stoelting P; Opitz CA; Sers C; Heiland I; Schäuble S; Thedieck K
    Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30923191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: Cellular and biochemical studies.
    Khorsandi K; Hosseinzadeh R; Shahidi FK
    J Cell Biochem; 2019 Apr; 120(4):4998-5009. PubMed ID: 30302810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
    Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
    Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective photocytotoxicity of anthrols on cancer stem-like cells: The effect of quinone methides or reactive oxygen species.
    Uzelac L; Škalamera Đ; Mlinarić-Majerski K; Basarić N; Kralj M
    Eur J Med Chem; 2017 Sep; 137():558-574. PubMed ID: 28633106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light.
    Mikulich A; Kavaliauskiene S; Juzenas P
    Biochim Biophys Acta; 2012 Jul; 1820(7):870-7. PubMed ID: 22507270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential role of Marine Bioactive Compounds in cancer signaling pathways: A review.
    Manoharan S; Perumal E
    Eur J Pharmacol; 2022 Dec; 936():175330. PubMed ID: 36265609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment.
    Al Amin M; Emran TB; Khan J; Zehravi M; Sharma I; Patil A; Gupta JK; Jeslin D; Krishnan K; Das R; Nainu F; Ahmad I; Wilairatana P
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.